Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference20 articles.
1. Lenvatinib treatment of advanced RAI-refractory differentiated thyroid cancer (DTC): Cytokine and angiogenic factor (CAF) profiling in combination with tumor genetic analysis to identify markers associated with response;Ball;J. Clin. Oncol.,2012
2. Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases;da Silva;Modern Pathol.: Off. J. U. S. Can. Acad. Pathol. Inc.,2021
3. Mesonephric-like adenocarcinoma of the endometrium: diagnostic advances to spot this wolf in sheep’s clothing. A review of the literature;Deolet;J. Clin. Med.,2021
4. Mesonephric-like carcinoma of the endometrium: A subset of endometrial carcinoma with an aggressive behavior;Euscher;Am. J. Surg. Pathol.,2020
5. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma;Horn;J. Cancer Res. Clin. Oncol.,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Special Considerations in Classification and Workup of Endometrial Carcinomas;Archives of Pathology & Laboratory Medicine;2023-11-06
2. Synchronous ovarian and uterine mesonephric‐like carcinoma that potentially arose from endometrioid adenofibroma: A case report;Journal of Obstetrics and Gynaecology Research;2023-01-03
3. Mesonephric-Like Adenocarcinoma of the Endometrium: Review of the Literature and Practical Diagnostic Recommendations;AJSP: Reviews and Reports;2022-09
4. Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution;Frontiers in Oncology;2022-07-05
5. Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior;Advances in Anatomic Pathology;2022-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3